Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CLB-3000 by ClearB Therapeutics for Hepatitis B: Likelihood of Approval
CLB-3000 is under clinical development by ClearB Therapeutics and currently in Phase I for Hepatitis B. According to GlobalData, Phase...